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Résumé en
anglais
Phenotypic characterisation of the human cytomegalovirus (HCMV) pUL54 DNA
polymerase is a useful tool for testing for mutations in the UL54 gene thought to
render HCMV resistant to foscarnet. In this study, an in-house non-isotopic method for
assessing polymerase enzymatic activity in the presence and absence of foscarnet was
developed and its utility for HCMV polymerase phenotyping evaluated. Polymerase
activity was assessed by monitoring the incorporation of digoxigenin-labelled
nucleotides into the growing DNA chain and foscarnet concentrations inhibiting
enzymatic activity by 50% were determined. HCMV DNA polymerases were
synthesised in vitro by expression of UL54 under the control of the T7 promoter.
Mutations of interest were introduced into the wild-type UL54 gene by site-directed
mutagenesis. Mutated polymerases and polymerases from HCMV reference strains
were studied. The activity of polymerases containing mutations known to confer
resistance to foscarnet (V715M, T700A and N495K) was inhibited by concentrations of
foscarnet eight to 14 times higher than those required to inhibit wild-type
polymerases. Our in-house non-radioactive phenotypic assay was sensitive and
reproducible. It is also easy to perform and could provide a convenient method for
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